Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity (Q40434261)

27890789

20 September 2017

title

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity (English)

1 reference

20 September 2017

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Satomi Shimura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Koichi Watashi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Kento Fukano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Michael Peel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Ann Sluder

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Masashi Iwamoto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Senko Tsukuda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Junko S Takeuchi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Takeshi Miyake

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Masaya Sugiyama

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Yuki Ogasawara

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sam-Yong Park

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Yasuhito Tanaka

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Hiroyuki Kusuhara

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Masashi Mizokami

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Camille Sureau

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Takaji Wakita

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

1 reference

24 November 2016

1 reference

27890789

20 September 2017

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

685-692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).

6 June 2020

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin, for the treatment of HCV infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

New therapeutic agents for chronic hepatitis B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Strategies to inhibit entry of HBV and HDV into hepatocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID)

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

What determines the natural history of recurrent hepatitis C after liver transplantation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Antiviral treatment of hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Management of patients with hepatitis B who require immunosuppressive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Sodium-dependent taurocholic cotransporting polypeptide: a candidate receptor for human hepatitis B virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

The ins and outs of hepatitis C virus entry and assembly

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Curing a viral infection by targeting the host: the example of cyclophilin inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Molecular biology of hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Cyclophilin and viruses: cyclophilin as a cofactor for viral infection and possible anti-viral target.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

NTCP and beyond: opening the door to unveil hepatitis B virus entry

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Cyclophilins as modulators of viral replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Cyclosporine: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Virus entry mediated by hepatitis B virus envelope proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Identification of NTCP as an HBV receptor: the beginning of the end or the end of the beginning?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle

1 reference

https://pubmed.ncbi.nlm.nih.gov/27890789

12 December 2020

10.1016/J.JHEP.2016.11.009

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

release_ia6uhcq2ffenfa7xlkuxl573a4

6 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ia6uhcq2ffenfa7xlkuxl573a4

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27890789%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

27890789

1 reference